Signal active
Organization
Contact Information
Overview
Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing ”off-the-shelf” allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical grade cells at scale.
About
Biotechnology, Therapeutics, Oncology
2022
1-10
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Cell BioEngines headquartered in New York, New York, United States, North America, operates in the Biotechnology, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $82.5M in funding across 60 round(s). With a team of 1-10 employees, Cell BioEngines is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - Cell BioEngines, raised $250.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
1
0
$1.4M
Details
4
Cell BioEngines has raised a total of $1.4M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2023 | Seed | 275.0K | ||
2023 | Seed | 250.0K | ||
2024 | Seed | 500.0K | ||
2024 | Seed | 250.0K |
Investors
Cell BioEngines is funded by 16 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Cell BioEngines | - | FUNDING ROUND - Cell BioEngines | 500.0K |
SOSV | - | FUNDING ROUND - SOSV | 500.0K |
Cell BioEngines | - | FUNDING ROUND - Cell BioEngines | 250.0K |
New York Ventures | - | FUNDING ROUND - New York Ventures | 250.0K |
Recent Activity
There is no recent news or activity for this profile.